Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast CancerGiulio Metro, Alessandra Fabi, Mariangela Ciccarese et al.|The Breast Journal|2009Cited by 11
Time to first tumor progression as outcome predictor of a second trastuzumab-based therapy beyond progression in HER2-positive metastatic breast cancerGiulio Metro, F. Cognetti, Alessandra Fabi et al.|Journal of Clinical Oncology|2008Cited by 3